US Cabergoline Tablets Market Drug Development and Innovation
The US cabergoline tablets market is supported by growing demand for pharmacological management of hyperprolactinemia and related hormonal disorders. Increasing diagnosis of prolactin-related conditions, greater awareness of treatment options, and the use of dopamine agonists in clinical practice are contributing to market demand. Improved access to specialized endocrine care and continued...
0 Comments
0 Shares